QUT genetic researchers have found blood proteins that cause migraine and have a shared link with Alzheimer's disease that could potentially be prevented by repurposing existing therapeutics.
May 12, 2022
0
82
In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...
Dec 27, 2022
0
107
A study by UT Southwestern researchers finds that changing the biochemistry of parts of brain cells abolished the formation of amyloid beta plaques in a mouse model of Alzheimer's disease. The finding, published in eLife, ...
Oct 29, 2021
0
73
An experimental drug can reduce the toxic changes in tau proteins known to damage neurons in brains with Alzheimer's disease, researchers from Yale School of Medicine and Johns Hopkins University report.
Nov 6, 2023
0
83
Like amyloid plaque, the genetic variant APOE4 has long been associated with Alzheimer's disease, but still little is known about the role the gene plays in the disease process.
Jun 14, 2021
0
18
Rice University scientists have uncovered new details about how a repeating nucleotide sequence in the gene for a mutant protein may trigger Huntington's and other neurological diseases.
Nov 10, 2016
0
45
New insights into the pathogenesis of Alzheimer's disease could unlock novel therapeutic approaches and help to prevent the disease. A study led by Professors Marcus Grimm and Tobias Hartmann at the Rhineland Campus of the ...
Nov 28, 2023
0
61
The Ultrasound and Elasticity Imaging Laboratory, led by Elisa Konofagou, Robert and Margaret Hariri Professor of Biomedical Engineering, develops novel, ultrasound-based techniques for both imaging and therapeutic applications.
Sep 13, 2023
0
46
In a study presented today at the Alzheimer's Association International Conference 2016, researchers at the Douglas Mental Health University Institute have explored how some people may develop the hallmarks of Alzheimer's ...
Jul 26, 2016
0
17
A study published today (December 5) in the Proceedings of the National Academy of Sciences (PNAS) demonstrates a customized, synthetic peptide's ability to selectively detect Alzheimer's disease.
Dec 5, 2022
0
46
